FDA warns of medication errors with nimodipine oral capsules

August 02, 2010

The FDA is reminding healthcare professionals that oral nimodipine capsules should be given only by mouth or through a nasogastric tube and should never be given by intravenous administration.
 

Lundbeck recalls two lots of NeoProfen

August 02, 2010

Lundbeck announced a voluntary nationwide recall of two lots of NeoProfen (ibuprofen lysine) Injection that failed to meet a visible particulate quality requirement.
 

Undeclared drug ingredients in ejaculoid XXTREME and stimuloid II

August 02, 2010

Nutraloid Labs and the FDA have announced a nationwide recall of some lots of Nutraloid Labs' ejaculoid XXTREME and stimuloid II, sold as dietary supplements.
 

Afluria labeling updated to include fever and febrile seizure risk

August 02, 2010

The Prescribing Information for Afluria (trivalent, inactivated, "split virus" influenza vaccine [Types A and B], from CSL Biotherapies) has been updated to inform healthcare professionals of an increased incidence of fever and febrile seizure among young children in Australia, mainly those <5years of age.
 

FDA advises against use of Miracle Mineral Solution

August 02, 2010

The FDA has warned consumers not to use Miracle Mineral Solution, an oral liquid also known as "Miracle Mineral Supplement" or "MMS."
 

FDA warns of unintentional exposure to estrogen with Evamist

July 29, 2010

The FDA has notified healthcare professionals and patients that it is reviewing reports of adverse effects from Evamist (estradiol transdermal spray, from Ther-Rx) in children who may have been unintentionally exposed to the drug through skin contact with women using this product.
 

FDA warns of eosinophilic pneumonia risk with Cubicin

July 29, 2010

The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).
 

FDA warns against unapproved intrauterine devices (IUDs)

July 26, 2010

The FDA is warning healthcare professionals not to use unapproved intrauterine devices (IUDs).
 

FDA warns of dangerous ingredients in Joyful Slim herb supplement

July 22, 2010

The FDA is warning consumers that Joyful Slim herb supplement, marketed as a natural herb for weight loss, contains undeclared desmethyl sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss.
 

Vialipro dietary supplement recalled

July 20, 2010

Good Health announced a voluntary recall of Vialipro, sold as a dietary supplement, after FDA lab analyses found certain batches of the product to contain undeclared sulfoaildenafil.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions